Filter Results
:
(922)
Show Results For
-
All HBS Web
(922)
- People (2)
- News (62)
- Research (754)
- Events (1)
- Multimedia (2)
- Faculty Publications (646)
Show Results For
-
All HBS Web
(922)
- People (2)
- News (62)
- Research (754)
- Events (1)
- Multimedia (2)
- Faculty Publications (646)
- 01 Dec 2010
- News
This Is What I Do
thus deserve our support.” The MJFF raises about $50 million a year. There are prominent backers, such as Google’s Sergey Brin and his wife, Anne Wojcicki, but nearly 55,000 other people made contributions last year. To date the MJFF has supported about ninety biotech...
View Details
- Research Summary
Overview
Dr. Crawford conducts research on innovation in the energy industry, with a special focus on emerging business models. She is developing several cases for the EC course, "21st Century Energy," that specifically examine innovations at the interface of IT and Energy — ...
View Details
Keywords:
Electricity;
Prosumer;
Smart Grid;
Blockchain;
Microgrid;
Electric Vehicles;
Batteries;
Energy Storage;
Ride-sharing;
Smart Cities;
Smart Buildings;
Smart Meters;
Demand Response;
"GMOs,";
Corporate Accountability;
Responsibilities To Society;
Environmental And Social Sustainability;
Leadership & Corporate Accountability;
Competitive Strategy;
Innovation Strategy;
Disruptive Innovation;
Research and Development;
Leadership;
Environmental Sustainability;
Energy Industry;
Energy Industry;
Energy Industry;
Energy Industry;
Energy Industry;
Europe;
Asia;
United States
- April 2022
- Teaching Note
CVS Health: Prescription for Transformation
By: Rosabeth Moss Kanter and Catarina Martinez
In 2021, new CEO Karen Lynch (named the most powerful woman in business) considered the next transformation phase for CVS Health (a Fortune 5 corporate giant). The 2018 acquisition of Aetna insurance brought her to the company as part of its long evolution from a...
View Details
- May 2018
- Case
The Multiple Myeloma Research Foundation's Answer Fund
By: Richard G. Hamermesh and Matthew G. Preble
Keywords:
Data Analytics;
Customer Focus and Relationships;
Customer Relationship Management;
Cost vs Benefits;
Investment Return;
Health Care and Treatment;
Innovation Leadership;
Intellectual Property;
Knowledge Sharing;
Knowledge Dissemination;
Leadership;
Leading Change;
Resource Allocation;
Goals and Objectives;
Marketing Communications;
Performance;
Programs;
Projects;
Business and Community Relations;
Business and Stakeholder Relations;
Networks;
Partners and Partnerships;
Research and Development;
Genetics;
Behavior;
Motivation and Incentives;
Social and Collaborative Networks;
Nonprofit Organizations;
Strategy;
Health Industry;
Health Industry;
Health Industry;
United States
- February 2018 (Revised April 2018)
- Case
Yunnan Baiyao: Transforming a Chinese State-Owned Enterprise
By: Michael Chu, William C. Kirby, Nancy Hua Dai and Yuanzhuo Wang
This case tells the story of how Wang Minghui, Chairman of Yunnan Baiyao Group since 1999, transformed a single-product traditional Chinese medicine (TCM) state-owned enterprise (SOE) into a major diversified consumer health player in China's highly competitive...
View Details
Keywords:
State-owned Enterprise (SOE);
Traditional Chinese Medicine;
Yunnan;
Yunnan Baiyao;
Consumer Health;
Enterprise Transformation;
Transformation;
Health;
Business History;
State Ownership;
Private Ownership;
Business Strategy;
Commercialization;
Competition;
Consumer Products Industry;
Consumer Products Industry;
Consumer Products Industry;
China
Chu, Michael, William C. Kirby, Nancy Hua Dai, and Yuanzhuo Wang. "Yunnan Baiyao: Transforming a Chinese State-Owned Enterprise." Harvard Business School Case 318-078, February 2018. (Revised April 2018.)
- January 2007 (Revised January 2007)
- Background Note
Note on the U.S. Food and Drug Administration
By: Robert F. Higgins, Richard G. Hamermesh and Virginia Fuller
Describes the U.S. FDA with particular emphasis on its role in the development of new drugs, biologic products, and medical devices today. Provides context for the drug approval process by describing the FDA's history and organizational structure.
View Details
Keywords:
Health;
Governance Compliance;
Policy;
Product Development;
Government and Politics;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
United States
Higgins, Robert F., Richard G. Hamermesh, and Virginia Fuller. "Note on the U.S. Food and Drug Administration." Harvard Business School Background Note 807-050, January 2007. (Revised January 2007.)
- December 2021
- Case
Zoetis
By: David E. Bell, Damien McLoughlin and Natalie Kindred
- 2018
- Working Paper
Information Provision and Innovation: Natural Experiment of Herbal Patent Prior Art Adoption at the United States and European Patent Offices
By: Prithwiraj Choudhury and Tarun Khanna
We exploit a natural experiment to study how codifying information about prior innovation affects subsequent innovation. A codified database of traditional Indian herbal formulations was adopted by the European Patent Office (EPO) and the U.S. Patent and Trademark...
View Details
Keywords:
Patents;
Plant-Based Agribusiness;
Ethnicity;
Health Care and Treatment;
Pharmaceutical Industry;
Pharmaceutical Industry;
China;
India
Choudhury, Prithwiraj, and Tarun Khanna. "Information Provision and Innovation: Natural Experiment of Herbal Patent Prior Art Adoption at the United States and European Patent Offices." Harvard Business School Working Paper, No. 14-079, February 2014. (Revised January 2018.)
- December 2010 (Revised April 2012)
- Background Note
Stalemate at the WTO: TRIPS, Agricultural Subsidies, and the Doha Round
By: Arthur A. Daemmrich
This note analyzes disputes over intellectual property enforcement and agricultural trade barriers at the center of the Doha Round of World Trade Organization (WTO) negotiations. Fundamental principles of intellectual property rights and agricultural subsidies are...
View Details
Keywords:
Agribusiness;
Trade;
Globalization;
Governance;
International Relations;
Intellectual Property;
Agreements and Arrangements;
Agriculture and Agribusiness Industry;
Agriculture and Agribusiness Industry
Daemmrich, Arthur A. "Stalemate at the WTO: TRIPS, Agricultural Subsidies, and the Doha Round." Harvard Business School Background Note 711-043, December 2010. (Revised April 2012.)
- 07 Jun 2019
- Book
Are You a Digital Manager?
need to build ecosystems, networks with those both inside and outside the organization. We are collecting data on how managers build partnerships, even with other industries, to gain insights into how to drive innovation in their organizations. For instance, a manager...
View Details
Keywords:
by Martha Lagace
- 07 Oct 2014
- First Look
First Look: October 7
(MMRC), and brought together a diverse body of academics, researchers, pharmaceutical and biotech companies, physicians, and patients to combine their efforts around the disease. The MMRF had helped facilitate clinical trials for...
View Details
Keywords:
Sean Silverthorne
- 02 Aug 2018
- News
Can Marketing Help Halt the Heroin Epidemic?
going to take care of themselves, meaning prescriber limits are coming down, the way that doctors are prescribing is changing, CDC have got guidelines, lawsuits against these pharmaceutical companies and the distributors. All those things...
View Details
- Web
Annual Report 2017 - Annual Report 2017
Riparian Pharmaceuticals UrSure Vaxess Technologies XGenomes More about the Life Lab HBX Three courses were launched on the School’s digital platform in 2016–2017, including Leading with Finance (Mihir Desai), Negotiation Mastery (Mike...
View Details
- January 2017 (Revised March 2017)
- Case
Royal DSM: From Continuous Transformation to Organic Growth
By: William W. George, Carin-Isabel Knoop and Amram Migdal
Royal DSM CEO Feike Sijbesma was pondering the challenges of shifting DSM’s global organization from the constant transformations of the past 100 years to creating organic growth. When Sijbesma took the helm as CEO in 2007, he further pushed and completed the company’s...
View Details
Keywords:
Organic Growth;
Organizational Change;
M&A;
Mergers And Acquisitions;
Divestment;
Business Ventures;
Business Divisions;
Business Growth and Maturation;
Restructuring;
Change;
Change Management;
Transformation;
Transition;
Engineering;
Chemicals;
Mining;
Ethics;
Values and Beliefs;
Finance;
Capital Markets;
Financial Markets;
Food;
Globalization;
Global Strategy;
Globalized Firms and Management;
Globalized Markets and Industries;
Health;
Nutrition;
History;
Leadership;
Leadership Development;
Leadership Style;
Leading Change;
Management;
Business or Company Management;
Growth and Development Strategy;
Growth Management;
Management Practices and Processes;
Management Style;
Organizations;
Corporate Social Responsibility and Impact;
Mission and Purpose;
Organizational Change and Adaptation;
Organizational Culture;
Organizational Design;
Ownership;
Public Ownership;
Performance;
Strategy;
Adaptation;
Consolidation;
Corporate Strategy;
Value;
Value Creation;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Europe;
Netherlands
George, William W., Carin-Isabel Knoop, and Amram Migdal. "Royal DSM: From Continuous Transformation to Organic Growth." Harvard Business School Case 317-063, January 2017. (Revised March 2017.)
- 24 Jul 2018
- First Look
New Research and Ideas, July 24, 2018
on, it pays its key cast and crew members the minimum salary stipulated by industry unions and only pays out sizeable bonuses if a movie’s box-office reaches certain levels, it gives its directors a great deal of creative control, and it...
View Details
Keywords:
Dina Gerdeman
- February 1985 (Revised July 1993)
- Case
Puritan Drug Co.
David Thomas takes his first sales management assignment and is faced with a sales rep revolt because of a possible territory reorganization. In addition, his sales division is performing well below the national average. Rewritten version of a case by R.Z. Sorenson.
View Details
Keywords:
Salesforce Management;
Conflict and Resolution;
Beauty and Cosmetics Industry;
Beauty and Cosmetics Industry;
Beauty and Cosmetics Industry
Moriarty, Rowland T., Jr. "Puritan Drug Co." Harvard Business School Case 585-158, February 1985. (Revised July 1993.)
- September 2003 (Revised February 2007)
- Case
PolyMedica Corporation (A)
By: David F. Hawkins and Jacob Cohen
The Securities and Exchange Commission and investors question PolyMedica Corp.'s practice of capitalizing rather than expensing of direct-response advertising.
View Details
Keywords:
Activity Based Costing and Management;
Business Earnings;
Advertising;
Private Sector;
Budgets and Budgeting;
Cost Management;
Capital Markets;
Marketing;
Private Equity;
Pharmaceutical Industry;
Pharmaceutical Industry
Hawkins, David F., and Jacob Cohen. "PolyMedica Corporation (A)." Harvard Business School Case 104-023, September 2003. (Revised February 2007.)
- July 2014 (Revised February 2015)
- Teaching Note
Johnson & Johnson: The Promotion of Wellness
By: John A. Quelch
The chief medical officer of Johnson & Johnson (J & J) is reflecting on forty years of sustained efforts by the company to improve employee wellness. The case reviews J & J's multiple wellness initiatives and efforts to measure their effectiveness. It also invites...
View Details
Keywords:
Empoylee Wellness Programs;
Human Resource Management;
Corporate Management Strategy;
Employee Engagement;
Human Resources;
Management;
Organizations;
Performance;
Personal Development and Career;
Programs;
Strategy;
Health Industry;
Health Industry;
Health Industry;
Health Industry;
North and Central America;
Europe;
Asia
- 18 Dec 2012
- First Look
First Look: December 18
assumptions are present in the structure of technology and labor flows within Silicon Valley and its surrounding areas. Our model further identifies how the lengths over which agglomerative forces operate influence the shapes and sizes of View Details
Keywords:
Carmen Nobel
- February 1993 (Revised August 1995)
- Case
Medicare Payment for Drugs and Medical Devices
Keywords:
Health Care and Treatment;
Business and Government Relations;
Medical Devices and Supplies Industry;
Medical Devices and Supplies Industry;
Medical Devices and Supplies Industry
Herzlinger, Regina E. "Medicare Payment for Drugs and Medical Devices." Harvard Business School Case 193-099, February 1993. (Revised August 1995.)